shortagewatch

Home / Companies / Paladin

Company family

Paladin: medicine shortages

As of 2 Nov 2026, 28 Paladin products have a reported shortage across 1 countries, covering 17 medicines.

Products short28rank #76 of 464
Medicines17active ingredients
Countries1/16
New in 90 days00 vs market pace
Typical duration4.4 yearsmedian so far
Manufacturing64%demand-driven 0%

Where

Canada28

Which therapeutic classes

Nervous system13Genito-urinary system and sex hormones4Dermatologicals4Cardiovascular system2Systemic hormones2Digestive tract and metabolism1Respiratory system1Musculoskeletal system1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
PaladinPaladin: Manufacturing problem 16 (57%)57%Paladin: Distribution or logistics 3 (11%)11%Paladin: Other 6 (21%)21%Paladin: Not stated 3 (11%)11%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

When its current shortages began

00001Dec: 0Jan ’25: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 0NovDec: 0Jan ’26: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 0Nov

Long-run trend in Canada

Canada dashboard
061218252017: 161620172018: 111120182019: 222220192020: 151520202021: 111120212022: 151520222023: 161620232024: 18182024

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Paladin28

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Paladin: 28 / 17Paladin

Further right: more products short. Higher: more different medicines affected.

Medicines short

MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Alprostadil322 Jul 2021Manufacturing problem2/16
Morphine37 Jan 2021Manufacturing problem8/16
Paracetamol317 Mar 2022Manufacturing problem10/16
Acetylsalicylic Acid, Combinations excl. Psycholeptics223 Apr 2023Not stated3/16
Apomorphine21 Oct 2023Manufacturing problem2/16
Fluocinonide21 Jan 2014Other1/16
Labetalol28 Nov 2024Manufacturing problem2/16
Thiamazole221 Jun 2024Manufacturing problem1/16
Betamethasone1not givenNot stated1/16
Bethanechol111 Dec 2023Manufacturing problem1/16
Diphenhydramine125 Oct 2023Distribution or logistics2/16
Flavoxate119 Mar 2008Other1/16
Flumetasone and Antibiotics112 Aug 2023Manufacturing problem1/16
Methadone11 Nov 2018Other4/16
Pizotifen12 Oct 2023Other1/16
Podophyllotoxin127 Sep 2019Distribution or logistics2/16
Tizanidine13 Oct 2012Other4/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.